Newrology
A fresh approach to helping patients thrive
A pipeline for patient-kind
Harmony Biosciences’ patient-focused drug development model uses patient insights to inform clinical research programs.
The Struggle to Stay Awake: Recognizing Pediatric Narcolepsy
In this television broadcast about pediatric narcolepsy from The Lifetime Network, sponsored by Harmony Biosciences, learn about this often underdiagnosed and misdiagnosed disorder and meet a mother who trusted her instincts to help her son.
Jan 12, 2026
Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation
Jan 7, 2026
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Dec 8, 2025
Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome
available now
Discover our Products
From discovery to delivery, Harmony Biosciences is committed to getting medicines to the people who need them most.
The Harmony Team
Meet our leaders who share an uncommon commitment for addressing patients’ unmet medical needs.
Senior Leadership